Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?
- PMID: 7730247
- DOI: 10.1007/BF01745077
Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?
Abstract
A number of hemostatic parameters reflecting the activation of coagulation and fibrinolysis were investigated in a prospective study of 24 patients undergoing cardiopulmonary bypass (CPB) during heart surgery. The patients were randomized to a group in which either a roller (group 1) or a centrifugal pump (group 2) was used. Blood samples were taken preoperatively, at the onset of and every 20 min during CPB, after the administration of protamine, and 4, 20, 44, and 68 h postoperatively. The groups did not differ significantly in hematocrit, fibrinogen, factor XIII, and antithrombin III. Significant differences in favor of group 2 during and after CPB were found in prothrombin fragment F1 + 2, plasmin-antiplasmin complex (PAP), thrombin-antithrombin complex (TAT), and D-dimer (F1 + 2 P < 0.01 after 80-min CPB, PAP P < 0.005 after 40-min CPB, TAT and D-dimer P < 0.05 after 100-min CPB, D-dimer and PAP P < 0.05 after protamine administration, TAT and F1 + 2 4 h after CPB). These findings indicate the activation of fibrinolysis preceding thrombin generation during cardiopulmonary bypass. In addition, we conclude that centrifugal blood pumping is beneficial in avoiding excessive activation of both coagulation and fibrinolysis.
Similar articles
-
Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.Ann Thorac Surg. 1993 May;55(5):1205-9. doi: 10.1016/0003-4975(93)90035-g. Ann Thorac Surg. 1993. PMID: 7684219 Clinical Trial.
-
Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.Pediatr Crit Care Med. 2014 Jun;15(5):e198-205. doi: 10.1097/PCC.0000000000000107. Pediatr Crit Care Med. 2014. PMID: 24614609
-
Autotransfusion in coronary artery bypass grafting: disparity in laboratory tests and clinical performance.J Thorac Cardiovasc Surg. 1999 Oct;118(4):610-7. doi: 10.1016/s0022-5223(99)70005-x. J Thorac Cardiovasc Surg. 1999. PMID: 10504624
-
[Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].Rinsho Ketsueki. 2010 Jan;51(1):20-8. Rinsho Ketsueki. 2010. PMID: 20134136 Review. Japanese. No abstract available.
-
Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?J Cardiovasc Pharmacol. 1996;27 Suppl 1:S50-7. doi: 10.1097/00005344-199600001-00011. J Cardiovasc Pharmacol. 1996. PMID: 8938284 Review.
Cited by
-
Reduced release of tissue factor by application of a centrifugal pump during cardiopulmonary bypass.Heart Vessels. 1998;13(3):147-51. doi: 10.1007/BF01747832. Heart Vessels. 1998. PMID: 10328185 Clinical Trial.
-
Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.J Thromb Thrombolysis. 2009 Jan;27(1):95-104. doi: 10.1007/s11239-007-0187-5. Epub 2008 Jan 23. J Thromb Thrombolysis. 2009. PMID: 18214639 Review.
-
Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation.Heart Vessels. 1996;11(6):310-7. doi: 10.1007/BF01747190. Heart Vessels. 1996. PMID: 9248850
-
Which factors have a great impact on coagulopathy and hemostatic impairment after cardiopulmonary bypass in cardiovascular surgery? An analysis based on rotational thromboelastometry.Gen Thorac Cardiovasc Surg. 2022 Mar;70(3):230-238. doi: 10.1007/s11748-021-01688-0. Epub 2021 Aug 13. Gen Thorac Cardiovasc Surg. 2022. PMID: 34386904
-
Interindividual variations in cytokine levels following cardiopulmonary bypass.Heart Vessels. 1997;12(3):119-27. doi: 10.1007/BF02767129. Heart Vessels. 1997. PMID: 9496462 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials